Kiniksa Pharmaceuticals International (KNSA) Receivables (2021 - 2026)
Kiniksa Pharmaceuticals International's Receivables was $23.49 million in Q2 2026, down 26.4% from $31.91 million a year earlier but up 1.1% from the prior quarter.
Powered by 
Analysis
Kiniksa Pharmaceuticals International (KNSA) Receivables (2021 - 2026) Analysis & Trends
At the end of FY2025, Receivables at Kiniksa Pharmaceuticals International came in at $15.59 million, down 62.6% from FY2024.
- Receivables shows a four-year compound annual growth rate of 40.6% (FY2021 to FY2025).
- In earlier years, Receivables was $41.72 million in FY2024 (+96.2%), $21.27 million in FY2023 (+4.7%), $20.32 million in FY2022 (+409.8%) and $3.99 million in FY2021.
- Quarterly Receivables has moved between $3.04 million (Q3 2023) and $51.74 million (Q3 2025) over five years.
- Compared with a year earlier, Receivables has declined for three straight quarters, with growth averaging 124.7% over the last eight quarters.
- The best year-over-year quarter for Receivables over five years was Q3 2024 (growth of 718.4%); the worst was Q1 2023 (a decline of 74.8%).
- Per Business Quant data, KNSA's Receivables in the three quarters before Q2 2026 was $23.22 million (Q1 2026), $15.59 million (Q4 2025) and $51.74 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 19.05 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 13.82 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 12.56 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 9.64 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 15.68 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 10.23 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 5.06 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 12.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 2.13 Bn |
| 10 | Kiniksa Pharmaceuticals International | 11.87 Bn | 10.61 Bn | 220.03 Mn | 23.49 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 23.49 Mn |
| Mar 31, 2026 | 23.22 Mn |
| Dec 31, 2025 | 15.59 Mn |
| Sep 30, 2025 | 51.74 Mn |
| Jun 30, 2025 | 31.91 Mn |
| Mar 31, 2025 | 40.07 Mn |
| Dec 31, 2024 | 41.72 Mn |
| Sep 30, 2024 | 24.89 Mn |
| Jun 30, 2024 | 20.45 Mn |
| Mar 31, 2024 | 16.00 Mn |
| Dec 31, 2023 | 21.27 Mn |
| Sep 30, 2023 | 3.04 Mn |
| Jun 30, 2023 | 24.65 Mn |
| Mar 31, 2023 | 7.42 Mn |
| Dec 31, 2022 | 20.32 Mn |
| Sep 30, 2022 | 11.16 Mn |
| Jun 30, 2022 | 7.81 Mn |
| Mar 31, 2022 | 29.44 Mn |
| Dec 31, 2021 | 3.99 Mn |
| Sep 30, 2021 | 3.22 Mn |
API Access
Kiniksa Pharmaceuticals International Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=KNSA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "KNSA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=KNSA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();